Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2014

View Archived Issues

Alteration of endothelial gene methylation patterns underlies atherosclerotic damage

Preclinical data on novel anti-human CCR9 MAb for leukemia

Covance to conduct phase I/II study of AM-1030 in atopic dermatitis

Amgen reports results from second phase III trial of AMG-416 in SHPT

Novel missense mutation in AR gene responsible for CAIS symptoms

Novartis invests in Gamida Cell

Positive phase III results seen with ceftazidime-avibactam in intra-abdominal infections

Hyaluronidse-2 as potential new marker for platelet activation and IBD

MediciNova discloses results from phase IIa study of ibudilast in opioid dependence

Globavir aims to launch combination of approved drugs for Ebola virus infection during 2014

GlaxoSmithKline describes progress on HCV NS5A Inhibitors

New CETP inhibitors patented by Chong Kun Dang Holdings

Acetylon Pharmaceuticals patents novel HD3 inhibitors

U.S. and Japanese group disclose new FIXa inhibitors

Chinese researchers synthesize new ALK inhibitors

Amakem divulges novel ROCK inhibitors

Cannabis Technologies developing CTI-091 for arthritis and joint disease

Mount Tam Biotechnologies licenses lupus candidate from Buck Institute

Phylogica to provide drug discovery services to Genentech

Evotec to provide compound management for Medicines for MMV's drug discovery initiatives

Altor BioScience receives NCI grant to support bladder cancer trial

FDA approves IND for ViaCyte's stem cell therapy for type 1 diabetes

FDA approves Genzyme's eliglustat for Type 1 Gaucher disease

Clinigen Group acquires Ethyol from AstraZeneca

Boehringer Ingelheim files NDA for fixed-dose combination of tiotropium and olodaterol for COPD

Janssen launches tapentadol for cancer pain in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...